Westhouse is currently developing a number of medical devices, including BreastCheck - a new low-cost, non-invasive breast cancer screening product which can act as a precursor to mammogram scanning. BreastCheck is due for launch in 2013.
Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) is pleased to announce that it has acquired 52% of the issued share capital of Quy Biosciences Limited (Quy) through private placement. The acquisition values Quy at GBP3.25m The company is currently seeking to acquire the remaining 48% of Quy's issued share capital.
The Company is pleased to announce that it has listed its $25m 5yr Bond on the Danish GXG Exchange - MTF Section with effect from today's date.
Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) today announces that it has commenced a 5m Euro (GBP3.9m) funding round to enable it to further expand its acquisition and development programmes.
Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) today announces that announce the appointment of Mr Alex Renny as Managing Director.
Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) today announces that its Chairman, Jack Kaye has joined in an advisory capacity, the Committee on Advanced Technology for the US based International Charity, "The Cure is Now". The Cure is Now (www.TheCureisNow.org) is committed to funding and supporting the highest quality research that has the greatest potential to make a significant impact on the scientific community and patients throughout the world.
Charles Antzelevitch, Ph.D., Executive Director and Director of Research for the Cardiac Research Institute at Masonic Medical Research Laboratory (MMRL), headquartered in Utica, New York, was an invited speaker at Cardiostim 2012 in Nice, France.
